First Trust Nasdaq Pharmaceuticals ETF – NASDAQ:FTXH
First Trust Nasdaq Pharmaceuticals ETF stock price today
$27.64
+0.40
+1.47%
Market closed
Open in 2 days
First Trust Nasdaq Pharmaceuticals ETF stock price monthly change
-2.85%
month
First Trust Nasdaq Pharmaceuticals ETF stock price quarterly change
-2.85%
quarter
First Trust Nasdaq Pharmaceuticals ETF stock price yearly change
+2.52%
year
First Trust Nasdaq Pharmaceuticals ETF key metrics
Market Cap | 15.76M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeFirst Trust Nasdaq Pharmaceuticals ETF stock price history
First Trust Nasdaq Pharmaceuticals ETF stock forecast
First Trust Nasdaq Pharmaceuticals ETF financial statements
First Trust Nasdaq Pharmaceuticals ETF other data
Wednesday, 14 August 2024 | ||
| Pharma ETFs in Focus Post Solid Q2 Earnings | zacks.com | |
Tuesday, 7 May 2024 | ||
| A Look at Pharma ETFs Post Q1 Earnings | Zacks Investment Research | |
Wednesday, 17 April 2024 | ||
| JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus | Zacks Investment Research | |
Monday, 12 February 2024 | ||
| A Look at Pharma ETFs After Q4 Earnings | Zacks Investment Research | |
Wednesday, 8 November 2023 | ||
| Pharma ETFs in Focus Post Q3 Earnings | Zacks Investment Research | |
Friday, 11 August 2023 | ||
| Pharma ETFs in Focus Post Q2 Earnings | Zacks Investment Research | |
Thursday, 22 June 2023 | ||
| Biotech ETFs in Focus on Covid Vaccines' Fall Rollout | Zacks Investment Research | |
Tuesday, 9 May 2023 | ||
| Pharma ETFs Gain Post Q1 Earnings | Zacks Investment Research | |
Wednesday, 11 January 2023 | ||
| Can Health Care Stocks Outperform Again In 2023? | Seeking Alpha | |
Wednesday, 14 December 2022 | ||
| 5 Best Sector ETFs of 2022 | Zacks Investment Research | |
Tuesday, 13 December 2022 | ||
| Amgen to Buy Horizon Therapeutics: ETFs to Bet On | Zacks Investment Research | |
Tuesday, 6 December 2022 | ||
| 2 Sector ETFs Hovering Around a 52-Week High | Zacks Investment Research | |
Wednesday, 9 November 2022 | ||
| Pharma ETFs in Focus Post Q3 Earnings | Zacks Investment Research | |
Thursday, 12 May 2022 | ||
| Pharma ETFs in Focus Post Q1 Earnings | Zacks Investment Research | |
Monday, 28 March 2022 | ||
| Pharma In Transition: Context And Opportunities | Seeking Alpha | |
Tuesday, 22 February 2022 | ||
| Solid Q4 Earnings Fail to Impress Pharma ETFs | Zacks Investment Research | |
Tuesday, 9 November 2021 | ||
| Wave of Solid Q3 Earnings Push Pharma ETFs Higher | Zacks Investment Research |
Horiba: Wonderful Japanese Company At A Very Attractive Price
Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
Pfizer: Sell-Off Overdone, Healthy Pipeline To Sustain Above 15% ROE
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
Circling Back On Precigen
Catalent: No Catalyst Just Yet
Dividend Aristocrat Johnson & Johnson: One Of The Best Ideas Out There
Zoetis: Lovable Company With Vision
Gilead Sciences - Improving Here
-
What's the price of First Trust Nasdaq Pharmaceuticals ETF stock today?
One share of First Trust Nasdaq Pharmaceuticals ETF stock can currently be purchased for approximately $27.64.
-
When is First Trust Nasdaq Pharmaceuticals ETF's next earnings date?
Unfortunately, First Trust Nasdaq Pharmaceuticals ETF's (FTXH) next earnings date is currently unknown.
-
Does First Trust Nasdaq Pharmaceuticals ETF pay dividends?
Yes, First Trust Nasdaq Pharmaceuticals ETF pays dividends and its trailing 12-month yield is 0.89% with 0% payout ratio. The last First Trust Nasdaq Pharmaceuticals ETF stock dividend of $0.04 was paid on 30 Sep 2021.
-
How much money does First Trust Nasdaq Pharmaceuticals ETF make?
First Trust Nasdaq Pharmaceuticals ETF has a market capitalization of 15.76M.
-
What is First Trust Nasdaq Pharmaceuticals ETF's stock symbol?
First Trust Nasdaq Pharmaceuticals ETF is traded on the NASDAQ under the ticker symbol "FTXH".
-
What is First Trust Nasdaq Pharmaceuticals ETF's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of First Trust Nasdaq Pharmaceuticals ETF?
Shares of First Trust Nasdaq Pharmaceuticals ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When First Trust Nasdaq Pharmaceuticals ETF went public?
First Trust Nasdaq Pharmaceuticals ETF is publicly traded company for more then 8 years since IPO on 22 Sep 2016.
First Trust Nasdaq Pharmaceuticals ETF company profile:
Exchange:
NASDAQ
Full time employees:
0
Industry:
Asset Management
Sector:
Financial Services
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
,
CIK: 0001552740
ISIN: US33738R8372
CUSIP: 33738R837
